Digoxin vs Pembrolizumab

## Digoxin vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Digoxin** and **Pembrolizumab**.

## Mechanism of Action

**Digoxin**: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Digoxin — 36-48 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Digoxin — C41H64O14; Pembrolizumab — N/A.

**Molecular Weight**: Digoxin — 780.9430 g/mol; Pembrolizumab — N/A.

**Type**: Digoxin — Small molecule; Pembrolizumab — Antibody.